
Combining radiotherapy with 6 months of androgen deprivation therapy doubles the survival chances of men with locally advanced prostate cancer, according to Australian researchers.

Combining radiotherapy with 6 months of androgen deprivation therapy doubles the survival chances of men with locally advanced prostate cancer, according to Australian researchers.

A new study on the use of PSA-based prostate cancer screening in the United States has found that many elderly men may be undergoing unnecessary prostate cancer screenings. At the same time, a significant percentage in their fifties are not being screened.

Using the pelvic organ prolapse quantification exam, the Elevate Anterior and Apical Prolapse Repair System (American Medical Systems, Minnetonka, MD) has demonstrated 6-month efficacy rates of stage 1 or less to be 86.3% for anterior and 98.8% for apical prolapse, according to findings from a prospective, multicenter study.

Robot-assisted radical prostatectomy is safe over the long term, with a major complication rate of less than 1%, say researchers at Henry Ford Hospital?s Vattikuti Urology Institute, Detroit.

GlaxoSmithKline has announced that it will no longer pursue global approval for the use of the 5-alpha-reductase inhibitor dutasteride (Avodart) to reduce the risk of prostate cancer.

Nearly three-fourths of men who receive androgen deprivation therapy post-radical prostatectomy gain significant weight in the first year, putting on an average of 4.2 kg, according to a recent study.

When clinicians engage men in discussions of treatment for prostate cancer, they should keep in mind the very real impact of obesity on the man's overall prognosis - a risk that for some men may be more significant than that presented by the malignancy.

Cauterizing Hunner's lesions can give huge relief to patients who have them. But there may be another way to get results that may be just as good with somewhat fewer risks-cystoscopic injection of the lesions with the steroid triamcinolone.

Pelvic lymph node dissection in patients undergoing robot-assisted laparoscopic prostatectomy is feasible, adds little time or morbidity to the procedure, and may provide important prognostic data.

While many older physicians retain excellent clinical skills into their seventh decade and beyond, questions have been raised about age-related illness in older clinicians and how it affects their ability to practice.

Only half (49%) of the young physicians who register for the urology residency match will eventually match, and 11% of those will leave the specialty for other fields after matching.

There are lots of savings to be extracted from the system if physicians can work together to remove excessive, unnecessary, and/or unnecessarily expensive treatments.

Despite limited comparative effectiveness data, the utilization of higher-cost therapies for localized prostate cancer such as minimally invasive radical prostatectomy and intensity-modulated radiation therapy is increasing dramatically in men 65 years of age and older.

The first-ever nationwide survey of antibiotic use in children with urinary tract infections found that the use of third-generation cephalosporins more than doubled between 1998 and 2007.

Children who undergo a double hydrodistention-implantation technique injection with dextranomer/hyaluronic acid for primary vesicoureteral reflux are at low risk for recurrence.

Today, pediatric urology remains on the frontier of medicine, leading the way in tissue engineering and antenatal surgery, and many more innovations are sure to follow.

Pre-surgical stress management provides biological as well as psychological benefits in men with prostate cancer undergoing radical prostatectomy.

A new study indicates that the amount of time men spend driving and the frequency with which they engage in sexual intercourse impact seminal parameters.

New data confirm earlier findings that hydrodistention-implantation technique is more effective than subureteric transurethral injection of dextranomer/hyaluronic acid for the treatment of vesicoureteral reflux in children.

In 10 years of NIDDK-sponsored clinical trials for interstitial cystitis, there hasn't been one treatment tested that made a significant difference for these patients-until now. That treatment is myofascial physical therapy.

In urology, NPPs are taking on more defined responsibilities.

Hand-assisted laparoscopic renal surgery is safe and effective with a smaller learning curve than standard laparoscopy.

Urology drugs and devices that are in the pipeline from Auxilium Pharmaceuticals, Inc., Bavarian Nordic, Antares Pharma, Inc., Endo Pharmaceuticals, Bioniche Life Sciences, Inc., and Pfizer Inc.

Opinions are mixed on the future of practicing urology in a private setting.

Renal cryoablation has its advantages and its champions within the urologic surgical world, but in at least one multicenter comparison of intermediate oncologic outcomes, it fell short of the results produced by laparoscopic partial nephrectomy.

An experimental scoring system has identified several key risk factors associated with the potential for renal damage and surgical intervention in vesicoureteral reflux.

Prostate cancer research using whole genome sequencing analysis may lead to the identification of novel therapeutic targets as well as diagnostic tools for identifying aggressive primary tumors and characterizing genomic changes associated with disease progression.

The role of nurse practitioners in pediatric urology is growing. With the increasing work force shortage in pediatric urology and urology in general-it has to.

The newest urology products and services from Thermo Fisher, Cardinal Health, Coker Group, and Dale Medical Products, Inc.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes U.S. interstitial cystitis trials that are currently recruiting participants as well as phase IV U.S. incontinence/overactive bladder trials. This list is current as of March 11, 2011. For more information, view the complete database at http://ClinicalTrials.gov.